Effient, also known as prasugrel, is prescribed to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) [1][2]. The typical starting dose for Effient is 60 mg, followed by a daily maintenance dose of 10 mg [1].
When should I take my first Effient dose?
The initial 60 mg dose of Effient is generally administered as a single oral dose as soon as possible after diagnosis in patients with ACS who are scheduled for PCI [1]. This timing is crucial for establishing therapeutic levels to prevent blood clots [3].
What if I miss a dose of Effient?
If a dose of Effient is missed, it should be taken as soon as possible unless the next dose is less than 12 hours away [1]. If the next dose is due in less than 12 hours, the missed dose should be skipped, and the patient should resume their regular dosing schedule [1]. It is important not to double the dose to compensate for a missed one [1].
How long do I need to take Effient after my procedure?
The duration of Effient treatment depends on the individual patient's clinical situation and risk factors for thrombotic events versus bleeding [1]. Generally, it is prescribed for at least 12 months following PCI, but this can be adjusted by a healthcare provider [1][4]. For patients with a history of myocardial infarction (MI), treatment may extend beyond 12 months [4].
What are the risks associated with Effient?
The primary risks associated with Effient are bleeding events, including major and minor bleeding [1]. Other potential side effects include anemia, dyspnea, and rash [1]. Patients with a history of stroke or transient ischemic attack (TIA) should not take Effient due to an increased risk of bleeding [1][5]. The drug also carries a black box warning regarding irreversible inhibition of platelet activation, leading to an increased risk of bleeding [1].
Can Effient be used with other medications?
Effient can interact with other medications, particularly other antiplatelet agents and anticoagulants, which can increase the risk of bleeding [1]. It is essential to inform a healthcare provider about all medications, including over-the-counter drugs and herbal supplements, before starting Effient [1][3].
What is the difference between Effient and Plavix?
Both Effient (prasugrel) and Plavix (clopidogrel) are P2Y12 inhibitors used to prevent blood clots in patients with ACS undergoing PCI [1][6]. However, Effient has demonstrated superior efficacy in reducing thrombotic cardiovascular events compared to Plavix in some studies, though it may be associated with a higher risk of bleeding [7][8]. The choice between the two often depends on individual patient factors and physician judgment [8].
What is the patent status of Effient?
Information regarding the patent status and expiration dates for Effient is available through resources like DrugPatentWatch.com [9]. Patent expiry can impact the availability of generic versions of the drug [9].
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s008lbl.pdf
[2] https://www.drugpatentwatch.com/medication/effient
[3] https://www.ncbi.nlm.nih.gov/books/NBK557881/
[4] https://www.heart.org/en/health-topics/heart-attack/treatment-after-a-heart-attack/antiplatelet-therapy
[5] https://pubmed.ncbi.nlm.nih.gov/18024954/
[6] https://www.uptodate.com/contents/clopidogrel-versus-prasugrel-drug-information
[7] https://www.nejm.org/doi/full/10.1056/NEJMoa0706429
[8] https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.108.806496
[9] https://www.drugpatentwatch.com/